We are evaluating diagnostics that are fit for the needs of older patients. This builds on the North East’s international reputation for excellence in the study of ageing and long-term conditions.
We are expanding our proficiency in evaluating diagnostic tests for infectious diseases. We are particularly focused on improved detection of sepsis and, more recently, COVID-19.
We are evaluating tests that identify patients who will respond to specific treatments. This will strengthen the North East's world leading expertise in cancer and inherited diseases.